PT941094E - Processo para o fabrico de suspensoes oftalmicas contendo brinzolamida - Google Patents

Processo para o fabrico de suspensoes oftalmicas contendo brinzolamida

Info

Publication number
PT941094E
PT941094E PT97939835T PT97939835T PT941094E PT 941094 E PT941094 E PT 941094E PT 97939835 T PT97939835 T PT 97939835T PT 97939835 T PT97939835 T PT 97939835T PT 941094 E PT941094 E PT 941094E
Authority
PT
Portugal
Prior art keywords
ophthalmal
manufacture
suspensions containing
brinzolamide
containing brinzolamide
Prior art date
Application number
PT97939835T
Other languages
English (en)
Inventor
Yusuf Ali
Robert E Beck
Rex C Sport
Original Assignee
Alcon Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Lab Inc filed Critical Alcon Lab Inc
Publication of PT941094E publication Critical patent/PT941094E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • A61K31/77Polymers containing oxygen of oxiranes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
PT97939835T 1996-12-11 1997-09-05 Processo para o fabrico de suspensoes oftalmicas contendo brinzolamida PT941094E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3282096P 1996-12-11 1996-12-11
US08/886,933 US6071904A (en) 1996-12-11 1997-07-02 Process for manufacturing ophthalmic suspensions

Publications (1)

Publication Number Publication Date
PT941094E true PT941094E (pt) 2002-05-31

Family

ID=26708929

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97939835T PT941094E (pt) 1996-12-11 1997-09-05 Processo para o fabrico de suspensoes oftalmicas contendo brinzolamida

Country Status (14)

Country Link
US (1) US6071904A (pt)
EP (1) EP0941094B1 (pt)
JP (1) JP3611863B2 (pt)
AT (1) ATE209917T1 (pt)
CA (1) CA2274680C (pt)
DE (2) DE122009000016I1 (pt)
DK (1) DK0941094T3 (pt)
ES (1) ES2169416T3 (pt)
FR (1) FR09C0022I2 (pt)
HK (1) HK1019704A1 (pt)
LU (1) LU91554I2 (pt)
NL (1) NL300388I2 (pt)
PT (1) PT941094E (pt)
WO (1) WO1998025620A1 (pt)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000001365A1 (en) * 1998-06-30 2000-01-13 Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab) Prolonged release ophthalmic compositions containing a fluoroquinolone
US20030008853A1 (en) * 2001-05-21 2003-01-09 Alcon, Inc. Method for treating dry eye disorders
EP1392355B1 (en) 2001-05-21 2007-02-14 Alcon, Inc. Use of proteasome inhibitors to treat dry eye disorders
US6872382B1 (en) 2001-05-21 2005-03-29 Alcon, Inc. Use of selective PDE IV inhibitors to treat dry eye disorders
US7112588B2 (en) * 2001-05-21 2006-09-26 Alcon, Inc. Use of proteasome inhibitors to treat dry eye disorders
MXPA03010632A (es) 2001-05-21 2004-03-09 Alcon Inc Uso de inhibidores de nf-kb para tratar trastornos de resequedad de ojos.
TWI298257B (en) 2001-05-31 2008-07-01 Allergan Inc Hypotensive lipid and timolol compositions and methods of using same
US6645994B1 (en) 2001-06-01 2003-11-11 Alcon, Inc. Method of treating dry eye disorders
ES2283756T3 (es) * 2002-03-01 2007-11-01 Novagali Pharma Sa Sistemas autoemulsionantes de administracion de farmaco para taxoides.
CN100341498C (zh) 2003-01-21 2007-10-10 千寿制药株式会社 含有2-氨基-3-(4-溴苯甲酰基)苯乙酸的水成液制剂
ATE497787T1 (de) * 2004-03-12 2011-02-15 Cipla Ltd Sterilisationsprozess für steroide
ES2428868T3 (es) * 2006-07-28 2013-11-12 Novagali Pharma S.A. Composiciones que contienen compuestos de amonio cuaternario
WO2008035246A2 (en) 2006-07-28 2008-03-27 Novagali Pharma Sa Compositions containing quaternary ammonium compounds
TWI544927B (zh) 2008-03-17 2016-08-11 愛爾康研究有限公司 具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物
TWI489997B (zh) * 2009-06-19 2015-07-01 Alcon Res Ltd 含有硼酸-多元醇錯合物之水性藥學組成物
WO2011067791A2 (en) 2009-12-03 2011-06-09 Lupin Limited Process for preparing pharmaceutical ophthalmic compositions
EP2394637A1 (en) * 2010-05-21 2011-12-14 Zaklady Farmaceutyczne Polpharma SA Process for obtaining sterile brinzolamide suspensions
PL2598118T3 (pl) 2010-07-29 2019-01-31 Allergan, Inc. Roztwory bimatoprost i tymolol bez środków konserwujących
US9061034B2 (en) 2010-07-29 2015-06-23 Allergan, Inc. Preservative free bimatoprost and timolol solutions
WO2012053011A2 (en) 2010-10-18 2012-04-26 Usv Limited Ophthalmic compositions comprising brinzolamide
US20130065888A1 (en) 2011-08-15 2013-03-14 Biserka Cetina-Cizmek Ophthalmic formulations and processes for their preparation
EP2638909A1 (en) 2012-03-15 2013-09-18 Azad Pharmaceutical Ingredients AG Process for preparing sterile Brinzolamide
GR1007906B (el) * 2012-03-22 2013-05-30 Φαρματεν Αβεε, Οφθαλμικο φαρμακευτικο σκευασμα περιεχον ενα αναστολεα καρβονικης ανυδρασης και μεθοδος για την παρασκευη αυτου
KR101966830B1 (ko) * 2012-05-09 2019-04-08 아이크롬 에스피에이 무균 활성 약제 성분의 제조 방법
US20150119386A1 (en) * 2012-05-21 2015-04-30 Aurobindo Pharma Limited Process for preparing opthalmic suspension of brinzolamide
US9649319B2 (en) 2012-10-11 2017-05-16 Indoco Remedies Limited Process for manufacturing sterile brinzolamide ophthalmic suspension
CN104721136A (zh) * 2013-02-21 2015-06-24 四川大学 一种布佐林胺眼用纳米混悬剂及其制备方法
UA116273C2 (uk) * 2013-10-17 2018-02-26 Сентісс Фарма Прайвет Лімітед Офтальмологічний фармацевтичний склад, що не містить консерванта
US9820991B2 (en) * 2013-11-08 2017-11-21 Sentiss Pharma Private Limited Pharmaceutical composition comprising brinzolamide
WO2015068105A1 (en) 2013-11-08 2015-05-14 Sentiss Pharma Private Limited An improved process for manufacturing sterile ophthalmic pharmaceutical suspensions
JP6487452B2 (ja) * 2014-01-24 2019-03-20 センティス ファーマ プライベート リミテッド ブリンゾラミドを含む医薬組成物
PL407710A1 (pl) 2014-03-28 2015-10-12 Instytut Farmaceutyczny Sposób wytwarzania preparatu kropli do oczu w postaci zawiesiny zawierającej brynzolamid i preparat wytworzony tym sposobem
JP6279395B2 (ja) * 2014-05-01 2018-02-14 東亜薬品株式会社 ブリンゾラミド懸濁性点眼液組成物の製造方法
ES2954412T3 (es) 2014-10-20 2023-11-22 Sentiss Pharma Private Ltd Solución oftálmica
TWI664965B (zh) * 2015-06-22 2019-07-11 新源生物科技股份有限公司 酪胺酸激酶抑制劑之眼用調配物、其使用方法、及其製備方法
CN107582519A (zh) * 2017-06-01 2018-01-16 合肥远志医药科技开发有限公司 一种布林佐胺滴眼液制剂及其制备方法
GR1009419B (el) 2017-11-07 2018-12-14 Φαρματεν Αβεε Οφθαλμικο φαρμακευτικο σκευασμα που περιεχει εναν συνδυασμο βρινζολαμιδης και βριμονιδινης και μεθοδος για την παρασκευη αυτου
AU2019259343B2 (en) 2018-04-25 2022-02-17 Shilpa Medicare Limited Ophthalmic compositions of brinzolamide
GR1009616B (el) * 2018-07-20 2019-10-11 Φαρματεν Α.Β.Ε.Ε. Οφθαλμικο φαρμακευτικο σκευασμα που περιεχει βρινζολαμιδη και τιμολολη και μεθοδος παρασκευης αυτου
MX2021014477A (es) 2019-05-29 2022-01-06 Lupin Ltd Nanoemulsion gelificante in situ de brinzolamida.
US20220105101A1 (en) * 2020-10-05 2022-04-07 Somerset Therapeutics, Llc Efficient brinzolamide and brimonidine compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378703A (en) * 1990-04-09 1995-01-03 Alcon Laboratories, Inc. Sulfonamides useful as carbonic anhydrase inhibitors
IL101537A (en) * 1991-04-17 1997-11-20 Merck & Co Inc OPHTHALMIC COMPOSITIONS COMPRISING COMBINATIONS OF A CARBONIC ANHYDRASE INHIBITOR AND A b-ADRENERGIC ANTAGONIST
ATE169499T1 (de) * 1992-02-21 1998-08-15 Alcon Lab Inc Topische antiglaukoma zusammensetzungen, enthaltend karbonhydrasehemmer und beta-blocker
US5362758A (en) * 1992-09-18 1994-11-08 Pfizer Inc. Ophthalmic piroxicam solution
US5346702A (en) * 1992-12-04 1994-09-13 Sterling Winthrop Inc. Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization
US5429824A (en) * 1992-12-15 1995-07-04 Eastman Kodak Company Use of tyloxapole as a nanoparticle stabilizer and dispersant
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
US5422116A (en) * 1994-02-18 1995-06-06 Ciba-Geigy Corporation Liquid ophthalmic sustained release delivery system

Also Published As

Publication number Publication date
CA2274680C (en) 2003-11-18
CA2274680A1 (en) 1998-06-18
NL300388I1 (nl) 2009-07-01
HK1019704A1 (en) 2000-02-25
EP0941094A1 (en) 1999-09-15
JP3611863B2 (ja) 2005-01-19
ES2169416T3 (es) 2002-07-01
DK0941094T3 (da) 2002-01-07
AU4183897A (en) 1998-07-03
NL300388I2 (nl) 2010-02-01
WO1998025620A1 (en) 1998-06-18
US6071904A (en) 2000-06-06
LU91554I2 (fr) 2009-06-22
ATE209917T1 (de) 2001-12-15
FR09C0022I1 (pt) 2009-09-25
DE69708912D1 (de) 2002-01-17
FR09C0022I2 (pt) 2010-06-11
DE122009000016I1 (de) 2009-06-25
EP0941094B1 (en) 2001-12-05
JP2000501749A (ja) 2000-02-15
DE69708912T2 (de) 2002-04-11
AU718079B2 (en) 2000-04-06

Similar Documents

Publication Publication Date Title
PT941094E (pt) Processo para o fabrico de suspensoes oftalmicas contendo brinzolamida
BR9406590A (pt) Processo para a produção de gelatina
BR9609277A (pt) Aço supermartensítico processo para a produção de artigos manufaturados de aço supermartensítico e os respectivos artigos manufaturados de aço supermartensítico
BR9508618A (pt) Processo integrado para a produção de lacteto
BR9403442A (pt) Silanos, processo para sua produção e aplicação dos ditos silanos
PT971913E (pt) Processo para a producao de estatinas semi-sinteticas atraves de novos intermediarios
PT102081A (pt) Aparelho de estampagem e processo para a fabricacao de placas de cablagem
ITMI950056A0 (it) Processo per la produzione di 10-oxo-10,11-diidro-sh- -dibenz(b,f) azepin-5-carbossiammide
BR9509842A (pt) Processo para produção de fosgênio
PT770687E (pt) Processo para a producao de nicotinamida
BR9403281A (pt) Peça de máquina aneliforme e processo para sua fabricação
BR9203999A (pt) Aplicador de hidrogel,e,processo para sua fabricacao
BR9302424A (pt) Policarbonato e processo para producao do mesmo
BR9602789A (pt) Processo para a produção de aminas aromáticas e catalisador
BR9607413A (pt) Processo para produçao de pentafluoretano e tetrafluorcloroetano
BR9406201A (pt) Processo para a produção de difluoro-metano
BR9505814A (pt) Tambor para congecção de pneumático e processo de fabricação de um esboço cru de pneumático
PT1027315E (pt) Processo para a producao de n-butanol.
BR9505251A (pt) Processo para a fabricação de um composto e composto obtido
PT915988E (pt) Processo para a producao fermentativa de cefalosporinas desaciladas
BR9609451A (pt) Processo para a produção de azeoh enanciomericamente puro e composto
PT1049723E (pt) Processo para o fabrico de inulina de chicoria
BR9600086A (pt) Processo para a produção de hidroxialcoxibenzofenonas
BR9407200A (pt) Processo para a fabricação de um TI-,V-ou ZR-Beta-Zeólito e Ti-,V-ou ZR-Beta-Zeólitos obtidos
BR9606085A (pt) Processo para a fabricação de anéis de vedação de grafita de inchamento